Abstract
When tobacco mosaic virus (TMV) and its isolated nucleic acid (TMV-RNA) were treated with nitrous acid, the nucleic acid was inactivated six times faster than the intact virus. Inactivation of both the infectious entities was exponential with treatment time to 0.1% level of survival. Eight different mutant phenotypes were scored after inactivation of TMV and TMV-RNA to 50, 10, 1.0, and 0.1% survival levels. Significantly more mutants in relation to unaltered isolates were induced at all levels of survival upon nitrous acid treatment of TMV than of TMV-RNA. Furthermore, the proportion of two specific mutant phenotypes was significantly greater in treated TMV than in treated TMV-RNA. No qualitative differences, however, were observed between the mutational spectra of nitrous acid-treated TMV and TMV-RNA. These results indicate that, in the intact virus, the viral capsid protects some of the sites involved in lethality; thus, proportionately more mutants are induced on nitrous acid treatment of TMV versus TMV-RNA.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BRAMMER K. W. Chemical modification of viral ribonucleic acid. II. Bromination and iodination. Biochim Biophys Acta. 1963 Jun 25;72:217–229. [PubMed] [Google Scholar]
- Diener T. O., Desjardins P. R. Factors affecting the stability of tobacco mosaic virus. I. Ribonuclease-induced protection of virus from alkaline degradation. Virology. 1966 May;29(1):15–25. doi: 10.1016/0042-6822(66)90191-7. [DOI] [PubMed] [Google Scholar]
- FRAENKEL-CONRAT H. Chemical modification of viral ribonucleic acid. I. Alkylating agents. Biochim Biophys Acta. 1961 Apr 29;49:169–180. doi: 10.1016/0006-3002(61)90880-0. [DOI] [PubMed] [Google Scholar]
- FRAENKEL-CONRAT H. Degradation of tobacco mosaic virus with acetic acid. Virology. 1957 Aug;4(1):1–4. doi: 10.1016/0042-6822(57)90038-7. [DOI] [PubMed] [Google Scholar]
- FRAENKEL-CONRAT H., SINGER B. RECONSTITUTION OF TOBACCO MOSAIC VIRUS. IV. INHIBITION BY ENZYMES AND OTHER PROTEINS, AND USE OF POLYNUCLEOTIDES. Virology. 1964 Jul;23:354–362. doi: 10.1016/0042-6822(64)90257-0. [DOI] [PubMed] [Google Scholar]
- GIERER A., SCHRAMM G. Infectivity of ribonucleic acid from tobacco mosaic virus. Nature. 1956 Apr 14;177(4511):702–703. doi: 10.1038/177702a0. [DOI] [PubMed] [Google Scholar]
- MUNDRY K. W., GIERER A. Die Erzeugung von Mutationen des Tabakmosaikvirus durch chemische Behandlung seiner Nucleinsäure in vitro. Z Vererbungsl. 1958;89(4):614–630. [PubMed] [Google Scholar]
- SCHUSTER H., SCHRAMM G. Bestimmung der biologisch wirksamen Einheit in der Ribosenucleinsäure des Tabakmosaikvirus auf chemischem Wege. Z Naturforsch B. 1958 Nov;13B(11):697–704. [PubMed] [Google Scholar]
- SCHUSTER H., WILHELM R. C. Reaction differences between tobacco mosaic virus and its free ribonucleic acid with nitrous acid. Biochim Biophys Acta. 1963 Apr 30;68:554–560. doi: 10.1016/0006-3002(63)90184-7. [DOI] [PubMed] [Google Scholar]
- SCHUSTER H., WITTMANN H. G. The inactivating and mutagenic action of hydroxylamine on tobacco mosaic virus ribonucleic acid. Virology. 1963 Apr;19:421–430. doi: 10.1016/0042-6822(63)90035-7. [DOI] [PubMed] [Google Scholar]
- SIEGEL A. Studies on the induction of tobacco mosaic virus mutants with nitrous acid. Virology. 1960 May;11:156–167. doi: 10.1016/0042-6822(60)90059-3. [DOI] [PubMed] [Google Scholar]
- Siegel A. Artificial production of mutants of tobacco mosaic virus. Adv Virus Res. 1965;11:25–60. doi: 10.1016/s0065-3527(08)60542-4. [DOI] [PubMed] [Google Scholar]
- Singer B., Fraenkel-Conrat H. Chemical modification of viral RNA. VI. The action of N-methyl-N'-nitro-N-nitrosoguanidine. Proc Natl Acad Sci U S A. 1967 Jul;58(1):234–239. doi: 10.1073/pnas.58.1.234. [DOI] [PMC free article] [PubMed] [Google Scholar]